Publikationen 2013

Shayegi N, Kramer M, Bornhäuser M, Schaich M, Schetelig J, Platzbecker U, Röllig C, Heiderich C, Landt O, Ehninger G, Thiede C, Study Alliance Leukemia (SAL) , Schulz-Abelius A, Friedrichsen K, Repp R, Helm G, Kiani A, Krost A, Thiel E, Baldus CD, Possinger K, Kühnhardt D, Görner M, Probst S, Weissinger F, Krümpelmann U, Pflüger KH, Diekmann C, Mayer J, Protivankova M, Hänel M, Herbst R, Pielken HJ, Hindahl H, Ehninger G, Schaich M, Mackensen A, Krause S, Geißler M, Bauer J, Serve H, Brandts C, Kiehl M, Stein W, Höffkes HG, Ranze O, Schmitz N, Stuhlmann R, Schmidt H, Buhrmann K, Dürk HA, Metzner D, Ho AD, Krämer A, Kaiser U, Bartholomäus A, Fauser AA, Basara N, Link H, Mahlmann S, Wolf M, Ritter B, Mantovani-Löffler L, Kürschner D, Neuhaus T, Hoffmann C, Fetscher S, Schmielau J, Lehnert H, Brüggemann S, Neubauer A, Sohlbach K, Schleyer E, Griesshammer M, Tischler HJ, Lutz L, Hentrich M, Berdel WE, Müller-Tidow C, Wandt H, Schäfer-Eckart K, Jakob A, Dresel I, Gaska T, Niemeyer E, Kozák T, Vydra J, Reichle A, Holler E, Heits F, Meinhardt A, Geer T, Hrusovsky I, Kanzler S, Reinel HH, Heidemann E, Kaesberger J, Aulitzky WE, Leimer L, Clemens MR, Mahlberg R, Frickhofen N, Fuhr HG, Einsele H, Goebeler ME, Sandmann M, Becker G:(2013)The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML.Blood. 2013;122(1): 83-92
Grenz S, Naschberger E, Merkel S, Britzen-Laurent N, Schaal U, Konrad A, Aigner M, Rau TT, Hartmann A, Croner RS, Hohenberger W, Stürzl M:(2013)IFN-?-driven intratumoral microenvironment exhibits superior prognostic effect compared with an IFN-?-driven microenvironment in patients with colon carcinoma.Am J Pathol. 2013;183(6): 1897-909
Hauschild A, Kölbl O, Mackensen A, Schadendorf D:(2013)[Foreword].Onkologie. 2013;36 Suppl 4(): 1
Hochhaus A, Lüftner D, Mackensen A:(2013)[Targeted therapy: old and new possibilities].Onkologie. 2013;36 Suppl 5(): 2-11
Mougiakakos D, Jitschin R, von Bahr L, Poschke I, Gary R, Sundberg B, Gerbitz A, Ljungman P, Le Blanc K:(2013)Immunosuppressive CD14(+)HLA-DR(low/neg) IDO(+) myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.Leukemia. 2013;27(2): 377-88
Stockmann P, Nkenke E, Englbrecht M, Schlittenbauer T, Wehrhan F, Rauh C, Beckmann MW, Fasching PA, Kreusch T, Mackensen A, Wullich B, Schett G, Spriewald BM:(2013)Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw.J Craniomaxillofac Surg. 2013;41(1): 71-5
Aigner M, Feulner J, Schaffer S, Kischel R, Kufer P, Schneider K, Henn A, Rattel B, Friedrich M, Baeuerle PA, Mackensen A, Krause SW:(2013)T lymphocytes can be effectively recruited for ex vivo and in vivo lysis of AML blasts by a novel CD33/CD3-bispecific BiTE antibody construct.Leukemia. 2013;27(5): 1107-15
Goldmann K, Hoffmann J, Eckl S, Spriewald BM, Ensminger SM:(2013)Attenuation of transplant arteriosclerosis by oral feeding of major histocompatibility complex encoding chitosan-DNA nanoparticles.Transpl Immunol. 2013;28(1): 9-13
Arnold ML, Heinemann FM, Horn P, Ziemann M, Lachmann N, Mühlbacher A, Dick A, Ender A, Thammanichanond D, Fischer GF, Schaub S, Hallensleben M, Mytilineos J, Hitzler WE, Seidl C, Doxiadis II, Spriewald BM:(2013)16(th) IHIW: anti-HLA alloantibodies of the of IgA isotype in re-transplant candidates.Int J Immunogenet. 2013;40(1): 17-20
Hoffmann MH, Bruns H, Bäckdahl L, Neregård P, Niederreiter B, Herrmann M, Catrina AI, Agerberth B, Holmdahl R:(2013)The cathelicidins LL-37 and rCRAMP are associated with pathogenic events of arthritis in humans and rats.Ann Rheum Dis. 2013;72(7): 1239-48
Agaimy A, Vassos N, Märkl B, Meidenbauer N, Köhler J, Spatz J, Hohenberger W, Haller F, Croner RS, Schneider-Stock R, Matzel K:(2013)Anorectal gastrointestinal stromal tumors: a retrospective multicenter analysis of 15 cases emphasizing their high local recurrence rate and the need for standardized therapeutic approach.Int J Colorectal Dis. 2013;28(8): 1057-64
Bükki J, Scherbel J, Stiel S, Klein C, Meidenbauer N, Ostgathe C:(2013)Palliative care needs, symptoms, and treatment intensity along the disease trajectory in medical oncology outpatients: a retrospective chart review.Support Care Cancer. 2013;21(6): 1743-50
Neumann S, Krause SW, Maschmeyer G, Schiel X, von Lilienfeld-Toal M:(2013)Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DAnn Hematol. 2013;92(4): 433-42
Helou M, Reisbeck M, Tedde SF, Richter L, Bär L, Bosch JJ, Stauber RH, Quandt E, Hayden O:(2013)Time-of-flight magnetic flow cytometry in whole blood with integrated sample preparation.Lab Chip. 2013;13(6): 1035-8
Jitschin R, Mougiakakos D, von Bahr L, Völkl S, Moll G, Ringden O, Kiessling R, Linder S, Le Blanc K:(2013)Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantation.Stem Cells. 2013;31(8): 1715-25
Agaimy A, Brueckl V, Schmidt D, Krieg S, Ullrich E, Meidenbauer N:(2013)Tuberculous and non-tuberculous granulomatous lymphadenitis in patients receiving imatinib mesylate (glivec) for metastatic gastrointestinal stromal tumor.Case Rep Oncol. 2013;6(1): 134-42
Mohr B, Schetelig J, Schäfer-Eckart K, Schmitz N, Hänel M, Rösler W, Frickhofen N, Link H, Neubauer A, Schuler U, Platzbecker U, Middeke JM, Ehninger G, Bornhäuser M, Schaich M, Stölzel F, Study Alliance Leukaemia (SAL):(2013)Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia.Br J Haematol. 2013;161(2): 237-44
Hansen L, Tawamie H, Murakami Y, Mang Y, ur Rehman S, Buchert R, Schaffer S, Muhammad S, Bak M, Nöthen MM, Bennett EP, Maeda Y, Aigner M, Reis A, Kinoshita T, Tommerup N, Baig SM, Abou Jamra R:(2013)Hypomorphic mutations in PGAP2, encoding a GPI-anchor-remodeling protein, cause autosomal-recessive intellectual disability.Am J Hum Genet. 2013;92(4): 575-83
Meintker L, Ringwald J, Rauh M, Krause SW:(2013)Comparison of Automated Differential Blood Cell Counts From Abbott Sapphire, Siemens Advia 120, Beckman Coulter DxH 800, and Sysmex XE-2100 in Normal and Pathologic Samples.Am J Clin Pathol. 2013;139(5): 641-50
Schaich M, Parmentier S, Kramer M, Illmer T, Stölzel F, Röllig C, Thiede C, Hänel M, Schäfer-Eckart K, Aulitzky W, Einsele H, Ho AD, Serve H, Berdel WE, Mayer J, Schmitz N, Krause SW, Neubauer A, Baldus CD, Schetelig J, Bornhäuser M, Ehninger G:(2013)High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial.J Clin Oncol. 2013;31(17): 2094-102
Schorb E, Kasenda B, Atta J, Kaun S, Morgner A, Hess G, Elter T, von Bubnoff N, Dreyling M, Ringhoffer M, Krause SW, Derigs G, Klimm B, Niemann D, Fritsch K, Finke J, Illerhaus G:(2013)Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation.Haematologica. 2013;98(5): 765-70
Wolff D, Ayuk F, Elmaagacli A, Bertz H, Lawitschka A, Schleuning M, Meyer RG, Gerbitz A, Hilgendorf I, Hildebrandt GC, Edinger M, Klein S, Halter J, Mousset S, Holler E, Greinix HT:(2013)Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers.Biol Blood Marrow Transplant. 2013;19(5): 767-76
Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, Dill D, Dippel E, Eigentler T, Feyer P, Follmann M, Frerich B, Ganten MK, Gärtner J, Gutzmer R, Hassel J, Hauschild A, Hohenberger P, Hübner J, Kaatz M, Kleeberg UR, Kolbl O, Kortmann RD, Krause-Bergmann A, Kurschat P, Leiter U, Link H, Loquai C, Löser C, Mackensen A, Meier F, Mohr P, Möhrle M, Nashan D, Reske S, Rose C, Sander C, Satzger I, Schiller M, Schlemmer HP, Strittmatter G, Sunderkötter C, Swoboda L, Trefzer U, Voltz R, Vordermark D, Weichenthal M, Werner A, Wesselmann S, Weyergraf AJ, Wick W, Garbe C, Schadendorf D:(2013)S3-leitlinie ,,diagnostik, therapie und nachsorge des melanoms" - kurzfassung.J Dtsch Dermatol Ges. 2013;11(6): 563-94
Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, Dill D, Dippel E, Eigentler T, Feyer P, Follmann M, Frerich B, Ganten MK, Gärtner J, Gutzmer R, Hassel J, Hauschild A, Hohenberger P, Hübner J, Kaatz M, Kleeberg UR, Kolbl O, Kortmann RD, Krause-Bergmann A, Kurschat P, Leiter U, Link H, Loquai C, Löser C, Mackensen A, Meier F, Mohr P, Möhrle M, Nashan D, Reske S, Rose C, Sander C, Satzger I, Schiller M, Schlemmer HP, Strittmatter G, Sunderkötter C, Swoboda L, Trefzer U, Voltz R, Vordermark D, Weichenthal M, Werner A, Wesselmann S, Weyergraf AJ, Wick W, Garbe C, Schadendorf D:(2013)S3-Guideline "Diagnosis, therapy and follow-up of melanoma" - short version.J Dtsch Dermatol Ges. 2013;11(6): 563-602
Krause SW, Schildmann J, Lotze C, Winkler EC:(2013)Rationing cancer care: a survey among the members of the german society of hematology and oncology.J Natl Compr Canc Netw. 2013;11(6): 658-65
Meintker L, Haimerl M, Ringwald J, Krause SW:(2013)Measurement of immature platelets with Abbott CD-Sapphire and Sysmex XE-5000 in haematology and oncology patients.Clin Chem Lab Med. 2013;51(11): 2125-31
Gottfried E, Lang SA, Renner K, Bosserhoff A, Gronwald W, Rehli M, Einhell S, Gedig I, Singer K, Seilbeck A, Mackensen A, Grauer O, Hau P, Dettmer K, Andreesen R, Oefner PJ, Kreutz M:(2013)New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells.PLoS ONE. 2013;8(7): e66987
Goldmann K, Lauer B, Spriewald BM:(2013)Identification of the novel HLA-C*07:315 allele.Tissue Antigens. 2013;82(5): 354-5
Helm F, Kammertoens T, Lehmann FM, Wilke A, Bruns H, Mautner J, Bornkamm GW, Gerbitz A:(2013)Targeting c-MYC with T-Cells.PLoS ONE. 2013;8(10): e77375
Künzel J, Agaimy A, Krause SW, Vieth M, Alexiou C:(2013)Isolated late metastasis from testicular seminoma presenting as a parotid gland mass: case report and review of the literature.Curr Oncol. 2013;20(4): e354-8
Le Blanc K, Jitschin R, Mougiakakos D:(2013)Myeloid-derived suppressor cells in allogeneic hematopoietic stem cell transplantation: A double-edged sword?Oncoimmunology. 2013;2(7): e25009
Preidl RH, Eckl S, Ramsperger-Gleixner M, Koch N, Spriewald BM, Weyand M, Ensminger SM:(2013)Clopidogrel reduces post-transplant obliterative bronchiolitis.Transpl Int. 2013;26(10): 1038-48
Böll B, Goergen H, Arndt N, Meissner J, Krause SW, Schnell R, von Tresckow B, Eichenauer DA, Sasse S, Fuchs M, Behringer K, Klimm BC, Naumann R, Diehl V, Engert A, Borchmann P:(2013)Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the german hodgkin study group.J Clin Oncol. 2013;31(35): 4431-7
Charwat V, Rothbauer M, Tedde SF, Hayden O, Bosch JJ, Muellner P, Hainberger R, Ertl P:(2013)Monitoring Dynamic Interactions of Tumor Cells with Tissue and Immune Cells in a Lab-on-a-Chip.Anal Chem. 2013;85(23): 11471-8
Künzel J, Agaimy A, Krause S, Vieth M, Alexiou C:(2013)Isolated late metastasis from testicular seminoma presenting as a parotid gland mass: Case report and review of the literatureVirchows Arch. 2013;463(2): 164-165
Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, Dill D, Dippel E, Eigentler T, Feyer P, Follmann M, Frerich B, Ganten MK, Gärtner J, Gutzmer R, Hassel J, Hauschild A, Hohenberger P, Hübner J, Kaatz M, Kleeberg UR, Kölbl O, Kortmann RD, Krause-Bergmann A, Kurschat P, Leiter U, Link H, Loquai C, Löser C, Mackensen A, Meier F, Mohr P, Möhrle M, Nashan D, Reske S, Rose C, Sander C, Satzger I, Schiller M, Schlemmer HP, Strittmatter G, Sunderkötter C, Swoboda L, Trefzer U, Voltz R, Vordermark D, Weichenthal M, Werner A, Wesselmann S, Weyergraf AJ, Wick W, Garbe C, Schadendorf D:(2013)Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".J Dtsch Dermatol Ges. 2013;11 Suppl 6(): 1-116, 1-126

Publikationen 2013

Publikationen 2013

Notfall

Notfallinformationen UKER

Patienten & Besucher

Ärzte & Zuweiser

Forschung

Lehre